Autonomix Medical, Inc. (AMIX) Stock Forecast
AMIX analyst forecast
as of October 18, 2026- Analyst consensus
- Strong buy 4.50 / 5 from 2 analysts
- Price target
- $75.60 average of analyst targets
- Upside to target
- +2,557.3% from the latest close
- Next earnings
- November 11, 2026
- 52-week range
- $2.75 – $24.15
AMIX analyst ratings
2 analystsNumber of analysts at each rating.
AMIX price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
AMIX earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$5.88 | −$5.88 | −$5.88 | −$28.98 | +79.7% | 1 |
| Next quarter (Dec '26) | −$5.46 | −$5.46 | −$5.46 | −$7.56 | +27.8% | 1 |
| Current fiscal year (FY2027) | −$21.84 | −$21.84 | −$21.84 | −$48.72 | +55.2% | 1 |
| Next fiscal year (FY2028) | −$20.16 | −$20.16 | −$20.16 | −$21.84 | +7.7% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
AMIX revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0 | $0 | $0 | 0.0% | 2 |
| Next quarter (Dec '26) | $0 | $0 | $0 | 0.0% | 2 |
| Current fiscal year (FY2027) | $0 | $0 | $0 | 0.0% | 2 |
| Next fiscal year (FY2028) | $0 | $0 | $0 | 0.0% | 2 |
AMIX EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
AMIX EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$6.20 | −$6.20 | −$6.20 | −$6.20 | −$5.88 | −5.1% | 1 up · 1 down |
| Next quarter (Dec '26) | −$5.36 | −$5.36 | −$5.36 | −$5.36 | −$5.46 | +2.0% | 1 up · 1 down |
| Current fiscal year (FY2027) | −$22.68 | −$22.68 | −$22.68 | −$22.68 | −$21.84 | −3.7% | 1 up · 1 down |
| Next fiscal year (FY2028) | −$19.53 | −$19.53 | −$19.53 | −$19.53 | −$20.16 | +3.2% | 1 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
AMIX earnings surprises
Reported EPS vs the consensus estimate for the last 10 quarters; AMIX beat in 6 of 8.
What analysts expect from AMIX
2 analysts cover Autonomix Medical; their consensus rating is strong buy (4.50 on a 1–5 scale, where 5 is a strong buy). The average price target is $75.60, 2,557.3% above the latest close of $2.85. Analysts expect earnings of −$21.84 per share for FY2027, +55.2% from a year earlier. For FY2028 the average estimate is −$20.16 per share. Autonomix Medical beat the EPS estimate in 6 of the last 8 quarters.
Related: AMIX income statement, AMIX key metrics, AMIX chart. See the AMIX stock overview for the latest quote and news.
AMIX forecast FAQ
What is Autonomix Medical's price target?
The average analyst price target for Autonomix Medical is $75.60, 2,557.3% above the latest close of $2.85.
Is Autonomix Medical a buy, hold or sell?
Of 2 analysts covering Autonomix Medical, 1 rate it a strong buy, 1 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Autonomix Medical's EPS forecast?
Analysts forecast −$21.84 per share for FY2027 (range −$21.84 to −$21.84); for FY2028 the estimate is −$20.16.
When does Autonomix Medical report earnings?
Autonomix Medical is expected to report results for the quarter ending September 30, 2026 on November 11, 2026.
Does Autonomix Medical usually beat earnings estimates?
Autonomix Medical reported EPS at or above the analyst estimate in 6 of the last 8 quarters.